Investor Overview
News
- Kindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in HorsesNovember 25, 2019 4:03 PM EST
- Kindred Biosciences to Participate in Stifel Healthcare Conference and Jefferies London Healthcare ConferenceNovember 14, 2019 4:05 PM EST
- Kindred Biosciences Announces Third Quarter 2019 Financial ResultsNovember 12, 2019 4:01 PM EST
Events
- Thursday, November 21, 2019
- Tuesday, November 19, 2019 from 10:20 AM to 10:50 AM EST
- Tuesday, November 12, 2019 4:30 PM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Investor Overview
KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co...
Stock Information
News
Kindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in Horses
November 25, 2019
SAN FRANCISCO , Nov. 25, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Participate in Stifel Healthcare Conference and Jefferies London Healthcare Conference
November 14, 2019
SAN FRANCISCO , Nov. 14, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Third Quarter 2019 Financial Results
November 12, 2019
SAN FRANCISCO , Nov. 12, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...